ORMP
Oramed Pharmaceuticals Inc
Price:  
2.37 
USD
Volume:  
40,834.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORMP Probability of Bankruptcy

The Probability of Bankruptcy of Oramed Pharmaceuticals Inc (ORMP) is -% . This number represents the probability that ORMP will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating ORMP's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

ORMP - ESG ratings

ESG ratings are directly linked to the cost of capital and ORMP's ability to raise funding, both of which can significantly affect the probability of Oramed Pharmaceuticals Inc going bankrupt.

ESG Score 39.14
Environment Score 45.31
Social Score 20.76
Governance Score 51.36
Returns
Historical Returns (5 day) 0.86%
Historical Returns (MTD) -19.52%
Historical Returns (YTD) 1.73%
Historical Returns (13 week) 6.58%
Historical Returns (26 week) 6.82%
Historical Returns (52 week) 3.52%
Efficiency
Asset Turnover 0.02
Receiveable Turnover -
Gross Margin 100.00%
Operating Margin -565.67%
Pretax Margin -195.52%
Net Margin -177.61%
Return on Asset (ROA) 2.88
Return on Equity (ROE) 3.59
Return on Investments (ROI) 2.98
Price Metrics
Market Cap (M) 96.03
Enterprise Value (M)
52 Week High 5.24
52 Week Low 1.68
Beta 1.85
Average Volume (10 day) 0.05
Average Volume (3 month) 0.05
Price / Earnings (P/E) 17.16
Price / Sales (P/S) 35.12
Earnings
EPS 0.13
Revenue CAGR (5 year) -13.07%
Risk
Current Ratio 3.06
Quick Ratio 3.05